This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (64)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Infectious Diseases, Other  • Pulmonary Diseases  • Pneumonia  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Deborah J. Cook, MD; Marin H. Kollef, MD

JAMA. 1998;279:1605-1606.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

NOSOCOMIAL pneumonia is a major cause of morbidity and the leading cause of death from hospital-acquired infections among adult patients admitted to intensive care units (ICUs).¹ This article summarizes recent studies that evaluate risk factors for ICU-acquired pneumonia in critically ill patients. There are several clinical implications of these studies. Risk factors offer prognostic information about the probability of developing lung infection in individual critically ill patients and in populations of such patients. They help us understand some of the pathophysiologic mechanisms that predispose to pneumonia in this setting. Moreover, these mechanistic insights may lead to the development of effective preventive strategies. Finally, risk stratification can highlight which patients may be most likely to benefit from pneumonia prophylaxis.

We searched MEDLINE from 1988 to the present for cohort studies of ICU patients in whom nosocomial pneumonia was diagnosed and that used multiple . . . [Full Text of this Article]

Findings

Comment

From the Departments of Medicine and Clinical Epidemiology, McMaster University, Hamilton, Ontario (Dr Cook), and the Department of Medicine, Washington University School of Medicine, St Louis, Mo (Dr Kollef).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Profound effect of study design factors on ventilator-associated pneumonia incidence of prevention studies: benchmarking the literature experience
Hurley
J Antimicrob Chemother 2008;61:1154-1161.
ABSTRACT | FULL TEXT  

Noninvasive Ventilation by Helmet or Face Mask in Immunocompromised Patients: A Case-Control Study
Rocco et al.
Chest 2004;126:1508-1515.
ABSTRACT | FULL TEXT  

Evidence-Based Clinical Practice Guideline for the Prevention of Ventilator-Associated Pneumonia
Dodek et al.
ANN INTERN MED 2004;141:305-313.
ABSTRACT | FULL TEXT  

Variability in Antibiotic Prescribing Patterns and Outcomes in Patients With Clinically Suspected Ventilator-Associated Pneumonia
Fowler et al.
Chest 2003;123:835-844.
ABSTRACT | FULL TEXT  

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
Rello et al.
Chest 2002;122:2115-2121.
ABSTRACT | FULL TEXT  

Risk Factors for Aspiration
Metheny
JPEN J Parenter Enteral Nutr 2002;26:S26-S33.
ABSTRACT  

Infection Control in the ICU
Eggimann and Pittet
Chest 2001;120:2059-2093.
ABSTRACT | FULL TEXT  

Predictors of Successful Extubation in Neurosurgical Patients
NAMEN et al.
Am. J. Respir. Crit. Care Med. 2001;163:658-664.
ABSTRACT | FULL TEXT  

Risk Factors for Developing Pneumonia within 48 Hours of Intubation
RELLO et al.
Am. J. Respir. Crit. Care Med. 1999;159:1742-1746.
ABSTRACT | FULL TEXT